Frequency and Consequences of Immune Checkpoint Inhibitor–Associated Inflammatory Changes in Different Organs: An Autopsy Study Over 13 -Years
Modern Pathology · 2025-04 · 38 (4) · 100683
DOI: 10.1016/j.modpat.2024.100683 ↗Kurz gefasst
Fachartikel in der Zeitschrift Modern Pathology, 2025-04. Verfasst von Umberto Maccio und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology and Molecular Pathology, University Hospital of Zurich, Zurich, Switzerland. Electronic address: Umberto.maccio@usz.ch. Hauptthemen laut MEDLINE: Immune Checkpoint Inhibitors, Inflammation, Neoplasms. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 85 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Universitätsspital Zürich.
Abstract (Originalsprache)
Although immune checkpoint inhibitors (ICIs) have revolutionized modern oncology, they are also associated with immune-related adverse events (irAEs). Previous histopathologic descriptions of organ-related inflammatory changes do not consider systemic effects of ICIs, because of the absence of comprehensive autopsy studies. We performed a retrospective study on 42 whole-body autopsies of patients treated with ICIs from January 2011 to March 2024 to determine the frequency, organ distribution, and morphology of ICI-associated inflammatory changes as well as their clinical relevance. Twenty-three of 42 (54.8%) patients presented irAEs with inflammatory changes in at least one organ. Most frequent irAEs were ICI-related hypophysitis (N = 12; 28.6%), myocarditis (N = 8; 19.0%), pneumonitis (N = 5; 11.9%), hepatitis (N = 6; 14.3%), and adrenalitis (N = 5; 11.9%). ICI-related inflammation was mainly characterized by lymphohistiocytic and macrophage-rich tissue infiltrates, whereas a granulomatous "sarcoid-like" reaction was observed in 1 patient. Cause of death was attributable to ICI therapy in 7 (16.7%) patients, with ICI-associated myocarditis as the most common cause of death (N = 5; 71.4%). Clinically, irAEs were unsuspected in 5 of 7 ICI-related deaths (71.4%). Among irAEs, myocarditis has been clinically undiagnosed in 5 out of 8 cases (62.5%). Encephalitis was identified only at autopsy in all cases (N = 2). Hypophysitis was clinically unsuspected in 8 of 12 (66.7%) cases. Patients who died from irAEs developed more frequently a complete tumor regression than patients who died from other causes (P = .018). Of note, ICI-related myocarditis and pneumonitis were both associated with a systemic occurrence irAEs. Our study demonstrates that some irAEs, especially myocarditis, hypophysitis, and encephalitis, are clinically underdiagnosed. Autopsy remains a valuable tool to monitor diagnostic accuracy and therapeutic side effects in patients who died under ICI therapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pathology and Molecular Pathology, University Hospital of Zurich, Zurich, Switzerland. Electronic address: Umberto.maccio@usz.ch.
- Department of Medical Oncology and Hematology, University Hospital of Zurich, Zurich, Switzerland; University of Zurich, Zurich, Switzerland.
- University of Zurich, Zurich, Switzerland; Department of Cardiology, University Heart Center, University Hospital of Zurich and University of Zurich, Zurich, Switzerland; Department of Cardiology, Center for Translation…
- University of Zurich, Zurich, Switzerland; Department of Endocrinology, Diabetology and Clinical Nutrition, University Hospital of Zurich, Zurich, Switzerland; The LOOP Zurich-Medical Research Center, Zurich, Switzerlan…
- Division of Medical Oncology, Hospital of Uster, Uster, Switzerland.
- Department of Pathology and Molecular Pathology, University Hospital of Zurich, Zurich, Switzerland.
Förderung
- Universitätsspital Zürich
Zitieren
APA
Maccio, U., Wicki, A., Ruschitzka, F., Beuschlein, F., Wolleb, S., Varga, Z., & Moch, H. (2025). Frequency and Consequences of Immune Checkpoint Inhibitor–Associated Inflammatory Changes in Different Organs: An Autopsy Study Over 13 -Years. Modern Pathology, 38(4), 100683. https://doi.org/10.1016/j.modpat.2024.100683
Vancouver
Maccio U, Wicki A, Ruschitzka F, Beuschlein F, Wolleb S, Varga Z, et al. Frequency and Consequences of Immune Checkpoint Inhibitor–Associated Inflammatory Changes in Different Organs: An Autopsy Study Over 13 -Years. Modern Pathology. 2025;38(4):100683. doi:10.1016/j.modpat.2024.100683
BibTeX
@article{Maccio2025,
author = {Maccio, Umberto and Wicki, Andreas and Ruschitzka, Frank and Beuschlein, Felix and Wolleb, Sibylle and Varga, Zsuzsanna and Moch, Holger},
title = {Frequency and Consequences of Immune Checkpoint Inhibitor–Associated Inflammatory Changes in Different Organs: An Autopsy Study Over 13 -Years},
journal = {Modern Pathology},
year = {2025},
volume = {38},
number = {4},
pages = {100683},
doi = {10.1016/j.modpat.2024.100683}
}
EUVIMED